Graduate College of Social Work, Center for Drug & Social Policy Research, University of Houston, 110HA Social Work, Houston, TX 77204-4013, USA.
Drug Alcohol Depend. 2011 Apr 1;114(2-3):233-6. doi: 10.1016/j.drugalcdep.2010.09.014. Epub 2010 Nov 13.
To assess the incidence and rate of transition to injecting among Mexican American noninjecting heroin users.
In a prospective cohort study of street-recruited MA-NIU in San Antonio, Texas, 2002-2005, participants were administered structured interviews and tested for Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV). The analysis sample comprised former injection drug users (last injected >6 months ago, n=47) and those who had never injected drugs and tested HCV negative (n=219). A transition to injecting was defined as the first injection of illicit drugs since baseline interview. Transition rates were based on person-years at-risk (PYAR). Proportional hazards regression was used to estimate crude and adjusted (for significant differences between former and never injectors) hazard ratios and 95% confidence intervals of injecting history on transitioning to injecting.
Sixty-three (24%) participants transitioned to injecting at a rate of 22.3/100 PYAR (95% CI: 17.2-28.2). Former-injectors were significantly more likely to transition than never injectors (43% or 20/47 vs. 20% or 43/219; p<0.001), and did so at a faster rate (40.4/100 PYAR, 95% CI: 24.6-60.0 vs. 18.5/100 PYAR, 95% CI: 13.4-24.4), with the crude HR=1.931 (95% CI: 1.116, 3.341) and adjusted HR=2.263 (95% CI: 1.192-4.294).
The rate of transitioning to injecting was high and greater among former injectors. Of particular concern is the high rate of injecting initiation among never injectors. Future analyses will examine factors associated with injecting initiation, including individual susceptibility and behaviors, social networks, and the cultural and drug market context.
评估墨西哥裔美国非注射海洛因使用者转变为注射吸毒者的发生率和速度。
在德克萨斯州圣安东尼奥市进行的一项街头招募的 MA-NIU 前瞻性队列研究中,2002-2005 年,对参与者进行了结构化访谈和人类免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)检测。分析样本包括以前的注射吸毒者(最后一次注射>6 个月,n=47)和从未注射过毒品且 HCV 检测为阴性的人(n=219)。将首次注射非法药物定义为从基线访谈以来的首次注射。基于风险期(PYAR)计算了转变为注射的转变率。采用比例风险回归估计了注射史对转变为注射的粗比值比和调整比值比(调整了以前和从未注射者之间的显著差异),以及 95%置信区间。
63 名(24%)参与者转变为注射者,注射率为 22.3/100 PYAR(95%CI:17.2-28.2)。以前的注射者比从未注射者更有可能转变(43%或 20/47 比 20%或 43/219;p<0.001),而且转变速度更快(40.4/100 PYAR,95%CI:24.6-60.0 比 18.5/100 PYAR,95%CI:13.4-24.4),粗 HR=1.931(95%CI:1.116,3.341),调整 HR=2.263(95%CI:1.192-4.294)。
转变为注射的速度很高,以前的注射者更高。特别令人关注的是从未注射过的人开始注射的比率很高。未来的分析将研究与注射开始相关的因素,包括个体易感性和行为、社交网络以及文化和毒品市场背景。